Name | Description | Size | Catalog # | Supplier | |
---|---|---|---|---|---|
C17 peptide | The peptide is used to C17 antibody ractivity. Purity >… | 5 mg, 1 mg | orb304975 |
BIORBYT LTD. |
More Info |
C17 Sphingosine | MW: 285.5 | 5 mg | sc-223852 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
C17 Sphingosine | MW: 285.5 | 25 mg | sc-223852A |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
Sphinganine-C17 | Structural Formula: C17H37NO2, Molecular Weight: 287.48,… | 1 mg | sc-474261 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
C17orf113 | Magic™ Membrane Protein Human C17orf113 (Chromosom… | n/a | MPC2760K |
CREATIVE BIOLABS, INC. |
More Info |
C17orf101 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb600037 |
BIORBYT LTD. |
More Info |
C17orf101 | n/a | 10 ug | orb529698 |
BIORBYT LTD. |
More Info |
C17orf28 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb600381 |
BIORBYT LTD. |
More Info |
C17orf47 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb601706 |
BIORBYT LTD. |
More Info |
C17orf53 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb600574 |
BIORBYT LTD. |
More Info |
C17orf58 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb599374 |
BIORBYT LTD. |
More Info |
C17orf59 | n/a | 10 ug | orb529279 |
BIORBYT LTD. |
More Info |
C17orf61 | n/a | 10 ug | orb527581 |
BIORBYT LTD. |
More Info |
C17orf62 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb602120 |
BIORBYT LTD. |
More Info |
C17orf63 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb601733 |
BIORBYT LTD. |
More Info |
C17orf64 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb600240 |
BIORBYT LTD. |
More Info |
C17orf65 | n/a | 10 ug | orb529194 |
BIORBYT LTD. |
More Info |
C17orf66 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb595541 |
BIORBYT LTD. |
More Info |
C17orf66 | n/a | 10 ug | orb530631 |
BIORBYT LTD. |
More Info |
C17orf67 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb598851 |
BIORBYT LTD. |
More Info |
C17orf74 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb598858 |
BIORBYT LTD. |
More Info |
C17orf75 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb603034 |
BIORBYT LTD. |
More Info |
C17orf78 | Vector will be determined during the manufacturing process, either pENTR22… | 10 ug | orb601491 |
BIORBYT LTD. |
More Info |
C17orf80 | n/a | 10 ug | orb530747 |
BIORBYT LTD. |
More Info |
C17orf82 | n/a | 10 ug | orb529378 |
BIORBYT LTD. |
More Info |
C17orf89 | n/a | 10 ug | orb528977 |
BIORBYT LTD. |
More Info |
C17orf97 | n/a | 10 ug | orb532083 |
BIORBYT LTD. |
More Info |
13C17-Mycophenolic Acid | An internal standard for the quantification of mycophenolic acid by GC- or… | 1.2 mL | 36359-12 |
CAYMAN CHEMICAL COMPANY |
More Info |
Ginkgolic Acid C17:1 | A phenolic acid with antibacterial and anticancer activities; inhibits EHE… | 1 mg | 35737-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
Ginkgolic Acid C17:1 | A phenolic acid with antibacterial and anticancer activities; inhibits EHE… | 10 mg | 35737-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
Ginkgolic Acid C17:1 | A phenolic acid with antibacterial and anticancer activities; inhibits EHE… | 5 mg | 35737-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
Recombinant Human Uncharacterized protein C17orf97 (C17orf97) | Sequence: 1-453aa, full length protein. Purity >85% (SDS-PAGE). MW: 46,413… | 0.05 mg (E. coli), 0.05 mg (Yeast), 0.2 mg (E. coli) | MBS1456144 |
MYBIOSOURCE INC. |
More Info |
C17-D-erythro-Sphingosine | Purity >98%. MW: 286 | 1 mg, 5 mg | MBS393608 |
MYBIOSOURCE INC. |
More Info |
C17ORF103 Protein | C17ORF103 is a recombinant protein. Purity > 95% (SDS-PA… | 5 µg, 20 µg, 1 mg, | abx261132 |
ABBEXA LTD |
More Info |
Ginkgolic acid C17:1 | C24H38O3, MW: 374.56, CAS: 111047-30-4 | 5 mg | sc-228252 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
Ginkgolic acid C17:1 | C24H38O3, MW: 374.56, CAS: 111047-30-4 | 10 mg | sc-228252A |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
Ginkgolic acid C17:1 | C24H38O3, MW: 374.56, CAS: 111047-30-4 | 20 mg | sc-228252B |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
Ginkgolic acid C17:1 | Ginkgolic acid C17:1 (GAC 17:1) JAK2 Src STAT3… | 100 mg, 250 mg, 1 g | orb1089530 |
BIORBYT LTD. |
More Info |
Ginkgolic acid C17:1 | Ginkgolic acid C17:1 can significantly inhibit enterohem… | 100 mg, 50 mg, 5 mg | orb1222867 |
BIORBYT LTD. |
More Info |
Ginkgolic Acid C17:1 | MW: 374.565 | 10 mg | orb259265 |
BIORBYT LTD. |
More Info |
Ginkgolic acid C17:1 | Purity > 98%. MW: 374.56 | 20 mg | orb1101623 |
BIORBYT LTD. |
More Info |
Ginkgolic acid C17:1 | Purity 99.81%. MW: 374.56 | 5 mg, 100 mg, 50 mg, 500 mg, 25 mg, 10 mg, 1 mg | orb1300169 |
BIORBYT LTD. |
More Info |
Ginkgolic Acid C17:2 | MW: 372.549 | 5 mg | orb1479723 |
BIORBYT LTD. |
More Info |
PRMT5-IN-C17 | Purity 98.00%. MW: 371.411 | 5 mg, 50 mg, 100 mg | orb1740050 |
BIORBYT LTD. |
More Info |
Sphinganine-C17-1-phosphate | Structural Formula: C17H38NO5P, Molecular Weight: 367.46… | 5 mg | sc-474257 |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
3-Acetyldeoxy Nivalenol-13C17 | An internal standard for the quantification of 3-acetyldeoxy nivalenol by… | 1.2 mL | 31258-12 |
CAYMAN CHEMICAL COMPANY |
More Info |
Aflatoxin B1-13C17 | An internal standard for the quantification of aflatoxin B1 by GC- or LC-MS | 1.2 mL | 31260-12 |
CAYMAN CHEMICAL COMPANY |
More Info |
Aflatoxin B2-13C17 | An internal standard for the quantification of aflatoxin B2 by GC- or LC-MS | 1.2 mL | 31261-12 |
CAYMAN CHEMICAL COMPANY |
More Info |
Aflatoxin G1-13C17 | An internal standard for the quantification of aflatoxin G1 by GC- or LC-MS | 1.2 mL | 31262-12 |
CAYMAN CHEMICAL COMPANY |
More Info |
Aflatoxin G2-13C17 | An internal standard for the quantification of aflatoxin G2 by GC- or LC-MS | 1.2 mL | 31263-12 |
CAYMAN CHEMICAL COMPANY |
More Info |
Aflatoxin M1-13C17 | An internal standard for the quantification of aflatoxin M1 by GC- or LC-MS | 1.2 mL | 31264-12 |
CAYMAN CHEMICAL COMPANY |
More Info |
C17 Ceramide (d18:1/17:0) | A synthetic ceramide; contains a non-natural C17:0 fatty… | 10 mg | 22532-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
C17 Ceramide (d18:1/17:0) | A synthetic ceramide; contains a non-natural C17:0 fatty… | 5 mg | 22532-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
C17 Globotriaosylceramide (d18:1/17:0) | A sphingolipid; has been used as an internal standard for the quantificati… | 500 µg | 24876-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
C17 Lactosylceramide (d18:1/17:0) | A naturally occurring sphingolipid; has been found in human brain metastas… | 1 mg | 24356-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
C17 Sphingomyelin (d18:1/17:0) | A synthetic derivative of sphingomyelin; has been used as an internal stan… | 10 mg | 25592-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
C17 Sphingomyelin (d18:1/17:0) | A synthetic derivative of sphingomyelin; has been used as an internal stan… | 25 mg | 25592-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
C17 Sphingomyelin (d18:1/17:0) | A synthetic derivative of sphingomyelin; has been used as an internal stan… | 5 mg | 25592-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
C17orf100 CytoSection | Transient overexpression of C17orf100 in HEK293T cells,… | 25 Slides | TS425049P5 |
ORIGENE TECHNOLOGIES |
More Info |
C17orf47 CytoSection | Transient overexpression of SEPTIN4 in HEK293T cells, FFPE control for IHC… | 25 Slides | TS406213P5 |
ORIGENE TECHNOLOGIES |
More Info |
C17orf49 CytoSection | Transient overexpression of C17orf49, transcript variant… | 25 Slides | TS426977P5 |
ORIGENE TECHNOLOGIES |
More Info |
C17orf49 CytoSection | Transient overexpression of C17orf49, transcript variant… | 25 Slides | TS423760P5 |
ORIGENE TECHNOLOGIES |
More Info |
C17orf58 CytoSection | Transient overexpression of C17orf58, transcript variant… | 25 Slides | TS407861P5 |
ORIGENE TECHNOLOGIES |
More Info |
C17orf64 CytoSection | Transient overexpression of C17orf64 in HEK293T cells, F… | 25 Slides | TS408296P5 |
ORIGENE TECHNOLOGIES |
More Info |
C17orf75 CytoSection | Transient overexpression of C17orf75 in HEK293T cells, F… | 25 Slides | TS401416P5 |
ORIGENE TECHNOLOGIES |
More Info |
C17orf78 CytoSection | Transient overexpression of C17orf78 in HEK293T cells, F… | 25 Slides | TS406656P5 |
ORIGENE TECHNOLOGIES |
More Info |
C17orf80 CytoSection | Transient overexpression of C17orf80, transcript variant… | 25 Slides | TS400157P5 |
ORIGENE TECHNOLOGIES |
More Info |
C17orf98 CytoSection | Transient overexpression of C17orf98 in HEK293T cells, F… | 25 Slides | TS423505P5 |
ORIGENE TECHNOLOGIES |
More Info |
Human Uncharacterized protein C17orf99, C17orf99 ELISA Kit | determine the level of C17OFR61 (hereafter termed analy… | 48-strip-wells, 96-strip-wells, 5x96-strip-wells | MBS9337680 |
MYBIOSOURCE INC. |
More Info |
Human Uncharacterized protein C17orf100 (C17orf100) ELISA Kit | Human Uncharacterized protein C17orf100 (C1… | 96 tests, | abx508531 |
ABBEXA LTD |
More Info |
Human Uncharacterized protein C17orf102 (C17orf102) ELISA Kit | Human Uncharacterized protein C17orf102 (C1… | 96 tests, | abx508533 |
ABBEXA LTD |
More Info |
Human Uncharacterized protein C17orf107 (C17orf107) ELISA Kit | Human Uncharacterized protein C17orf107 (C1… | 96 tests, | abx508537 |
ABBEXA LTD |
More Info |
Human Uncharacterized protein C17orf50 (C17orf50) ELISA Kit | Human Uncharacterized protein C17orf50 (C17… | 96 tests, | abx508493 |
ABBEXA LTD |
More Info |
Human Uncharacterized protein C17orf64 (C17orf64) ELISA Kit | Human Uncharacterized protein C17orf64 (C17… | 96 tests, | abx508505 |
ABBEXA LTD |
More Info |
Human Uncharacterized protein C17orf67 (C17orf67) ELISA Kit | Human Uncharacterized protein C17orf67 (C17… | 96 tests, | abx508509 |
ABBEXA LTD |
More Info |